Prodotto aggiunto correttamente al carrello.

discount label
Ac-Rpr-NH2
Visualizzare in 3D

Biosynth logo

Ac-Rpr-NH2

Rif. 3D-PP46153

Dimensione non definitaPrezzo su richiesta
Consegna stimata in Stati Uniti, il Martedì 10 Dicembre 2024

Informazioni sul prodotto

Nome:
Ac-Rpr-NH2
Sinonimi:
  • Ac-Rpr-amide
Descrizione:

Peptide Ac-Rpr-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-Rpr-NH2 include the following: Biochemical and Genetic Interactions betweenDrosophila Caspases and the Proapoptotic Genesrpr, hid, and grim Z Song , B Guan, A Bergman - and cellular biology, 2000 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1128/MCB.20.8.2907-2914.2000 Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and WS Lee, SM Moussaoui - British journal of , 1994 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1910223/ Degradation pathways of salmon calcitonin in aqueous solution V Windisch, F Deluccia, L Duhau - Journal of , 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1021/js9602305 Identification of novel short peptide inhibitors of soluble 37/48 kDa oligomers of amyloid beta42 T Kawasaki, K Onodera, S Kamijo - Bioscience, biotechnology, and , 2011 - jstage.jst.go.jphttps://www.jstage.jst.go.jp/article/bbb/75/8/75_110198/_article/-char/ja/ Hid, Rpr and Grim negatively regulate DIAP1 levels through distinct mechanisms SJ Yoo, JR Huh , I Muro, H Yu, L Wang, SL Wang - Nature cell , 2002 - nature.comhttps://www.nature.com/articles/ncb793 Simple peptides derived from the ribosomal core potentiate RNA polymerase ribozyme function S Tagami, J Attwater , P Holliger - Nature Chemistry, 2017 - nature.comhttps://www.nature.com/articles/nchem.2739 Peptide and non-peptide HIV fusion inhibitors S Jing, Q Zhao, AK Debnath - Current pharmaceutical design, 2002 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2002/00000008/00000008/art00002 Effects of RPR 100893, a potent NK1 antagonist, on the jaw-opening reflex in the guinea pig S Alia, J Azerad, B Pollin - Brain research, 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S000689939701545X First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B RP Giugliano, CH McCabe, RF Sequeira, MJ Frey - American Heart , 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0002870300911864 Hydrophobic-cationic peptides enhance RNA polymerase ribozyme activity by accretion P Li, P Holliger , S Tagami - bioRxiv, 2021 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2021.02.22.432394.abstract Hydrophobic-cationic peptides modulate RNA polymerase ribozyme activity by accretion P Li , P Holliger , S Tagami - Nature Communications, 2022 - nature.comhttps://www.nature.com/articles/s41467-022-30590-3 Comparison of three arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet aggregation OA EVANSON - 2004 - academia.eduhttps://www.academia.edu/download/70820958/j.1365-2885.2004.00592.x20210930-31025-1f5x9rh.pdf The conorfamide RPRFa stabilizes the open conformation of acid-sensing ion channel 3 via the nonproton ligand-sensing domain M Reiners, MA Margreiter , A Oslender-Bujotzek - Molecular , 2018 - ASPEThttps://molpharm.aspetjournals.org/content/94/4/1114.short Protamine-derived peptide RPR (Arg-Pro-Arg) ameliorates oleic acid-induced lipogenesis via the PepT1 pathway in HepG2 cells M Mijiti, R Mori, Y Nakashima, A Banno - Bioscience , 2023 - academic.oup.comhttps://academic.oup.com/bbb/article-abstract/87/2/197/6912243 Anti-obesity and hypocholesterolemic actions of protamine-derived peptide RPR (Arg-Pro-Arg) and protamine in high-fat diet-induced C57BL/6J mice M Mijiti, R Mori, B Huang, K Tsukamoto, K Kiriyama - Nutrients, 2021 - mdpi.comhttps://www.mdpi.com/2072-6643/13/8/2501 Structural basis for the recognition of RNA polymerase II C-terminal domain by CREPT and p15RS KR Mei , Z Jin, FL Ren, YY Wang, ZJ Chang - Science China Life , 2014 - Springerhttps://link.springer.com/article/10.1007/s11427-013-4589-7 Design of peptides interfering with iron-dependent regulator (IdeR) and evaluation of Mycobacterium tuberculosis growth inhibition H Salimizand, SA Jamehdar , LB Nik - Iranian Journal of , 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569447/ Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER GJ Pronk, K Ramer, P Amiri , LT Williams - Science, 1996 - science.orghttps://www.science.org/doi/abs/10.1126/science.271.5250.808 Pharmacological properties of RPR 102681, a novel CCK B antagonist GA Bohme, P Bertrand, O Piot, P Boudeau - Soc , 1997 - researchgate.nethttps://www.researchgate.net/profile/Georg-Bohme/publication/340264616_PHARMACOLOGICAL_PROPERTIES_OF_RPR_102681_A_NOVEL_CCK-B_ANTAGONIST/links/5e80a70392851caef4a96e26/PHARMACOLOGICAL-PROPERTIES-OF-RPR-102681-A-NOVEL-CCK-B-ANTAGONIST.pdf The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation FM Cutrer, S Moussaoui, C Garret, MA Moskowitz - Neuroscience, 1995 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0306452294004288 New degradable cationic peptides for modulated gene delivery F Mirkin, H Eini, A Douvdevani , G Byk - Peptides for Youth: The , 2009 - Springerhttps://link.springer.com/chapter/10.1007/978-0-387-73657-0_112 Biochemical characterization of casein kinase II as a protein kinase responsible for stimulation of HIV-1 protease in vitro E Haneda, T Furuya, S Asai, Y Morikawa - Biochemical and , 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X00933199 Evaluation of arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet function DJ Weiss, OA Evanson, RE Wells - American journal of , 1997 - Am Vet Med Assochttps://avmajournals.avma.org/view/journals/ajvr/58/5/ajvr.1997.58.05.457.xml Platelet kinetics in dogs treated with a glycoprotein IIb/IIIa peptide antagonist DJ Weiss, ML Mirsky, OA Evanson - Toxicologic , 2000 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/019262330002800211 A cell-permeable peptide-based PROTAC against the oncoprotein CREPT proficiently inhibits pancreatic cancer D Ma, Y Zou , Y Chu, Z Liu , G Liu, J Chu, M Li - Theranostics, 2020 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069095/ Stabilizers against heat-induced aggregation of RPR 114849, an acidic fibroblast growth factor (aFGF) CM Won, TE Molnar, RE McKean - International journal of , 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378517398000386 Reaper-Induced Apoptosis CL Holley - 2002 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA411241 Novel conformationally extended naphthalene-based inhibitors of farnesyltransferase CJ Burns, JD Guitton, B Baudoin - Journal of medicinal , 1997 - ACS Publicationshttps://pubs.acs.org/doi/full/10.1021/jm9701177 Preparation and purification of an immunoregulatory peptide from Stolephorus chinensis of the East Sea of China B Xu, L Ye, Y Tang, J Zheng, X Tian, Y Yang - Process Biochemistry, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S135951132030667X Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo B Schwartz , MA Ivanov, B Pitard, V Escriou, R Rangara - Gene therapy, 1999 - nature.comhttps://www.nature.com/articles/3300795 Peptide Antagonist B MCCULLOUGH - researchgate.nethttps://www.researchgate.net/profile/David-Mcclenahan/publication/12512959_Platelet_Kinetics_in_Dogs_Treated_with_a_Glycoprotein_IIbIIIa_Peptide_Antagonist/links/0c96051842b474b6a1000000/Platelet-Kinetics-in-Dogs-Treated-with-a-Glycoprotein-IIb-IIIa-Peptide-Antagonist.pdf

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP46153 Ac-Rpr-NH2

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".